Biologicals cohort (n=442) | CARRΈ study (n=283) | IRR (95%>CI) | |||
---|---|---|---|---|---|
Cases | IR (95%>CI)/1000 | Cases | IR (95%>CI)/1000 | ||
patientyears | patientyears | ||||
All CV events | 9 | 7.5 (3.9-14.4) | 32 | 23.2 (16.4-32.8) | 0.3 (0.1-0.6)* |
CV mortality | 0 | 0.0 (0.0-0.0) | 3 | 2.2 (0.7-6.7) | – |
CAD | 3 | 2.5 (0.8-7.8) | 18 | 13.0 (8.2-20.7) | 0.2 (0.1-0.7) * |
CVD | 6 | 5.0 (2.3-11.1) | 8 | 5.8 (2.9-16.8) | 0.9 (0.3-2.5) |
PAD | 0 | 0.0 (0.0-0.0) | 3 | 2.2 (0.7-6.7) | – |
CAD, coronary artery disease; CI, confidence interval; CV, cardiovascular; CVD, cerebrovascular disease; IR(R), incidence rate (ratio); PAD, peripheral arterial disease.